Yassine Bendiabdallah

Yassine Bendiabdallah

Direttore/Membro del Consiglio presso GENFLOW BIOSCIENCES PLC
Commercial Services
Consumer Services
Health Technology

Profilo

Yassine Bendiabdallah is the founder.
Dr. Bendiabdallah was the founder of Pasithea Therapeutics Corp., holding the title of COO, Director & Head-UK Clinics since 2020.
Dr. Bendiabdallah is also the founder of Purecare Ltd., Androgenix Pharmaceuticals Ltd., Zen Healthcare Center, Inc. Dr. Bendiabdallah is currently an Independent Non-Executive Director at Genflow Biosciences Plc since 2023, a Member of The Royal Society of Chemistry, and a Member of the Royal Pharmaceutical Society.
Dr. Bendiabdallah obtained a doctorate from the University of London in 2010 and a graduate degree from King's College London in 2006.

Posizioni attive di Yassine Bendiabdallah

SocietàPosizioneInizio
GENFLOW BIOSCIENCES PLC Direttore/Membro del Consiglio 11/05/2023
Purecare Ltd.
Amministratore Delegato -
Corporate Officer/Principal -
Corporate Officer/Principal -
Fondatore -

Precedenti posizioni note di Yassine Bendiabdallah

SocietàPosizioneFine
PASITHEA THERAPEUTICS CORP. Fondatore 14/09/2022
Androgenix Pharmaceuticals Ltd.
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di Yassine Bendiabdallah

Formazione di Yassine Bendiabdallah

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

87

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Purecare Ltd.

Androgenix Pharmaceuticals Ltd.

Health Services

  1. Mercati
  2. Insiders
  3. Yassine Bendiabdallah